VLDL receptor polymorphism, cognitive impairment, and dementia

Neurology
Nicole HelbecquePhilippe Amouyel

Abstract

Clinical, epidemiologic, and pathologic observations suggest that vascular risk factors are associated with impaired cognition. Previous studies supported an association between cognitive decline and APOE. Although the underlying mechanism is not clear, it might involve apoE receptors, such as the very low density lipoprotein receptor. The impact of a polymorphic triplet repeat in the very low density lipoprotein receptor gene (VLDLR) on cognitive function was examined in two independent studies: a population study involving 221 demented subjects compared with 249 control subjects and a clinical study involving 124 demented subjects compared with 179 control subjects. In the population study, the presence of the VLDLR-5-repeat allele was associated with a relative risk of dementia (OR, 1.9; 95% CI, 1.2 to 3.0). This result was confirmed in the clinical study (OR, 8.1; 95% CI, 4.4 to 15.1) and was more pronounced in subjects with mixed or vascular dementia than in patients with AD. The VLDLR-5-repeat allele may constitute a genetic susceptibility factor for dementia, particularly in the presence of vascular risk factors. This observation suggests the influence of vascular risk factors in the occurrence of dementia.

References

Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·P K FrykmanJ Herz
Nov 5, 1994·BMJ : British Medical Journal·E J FeskensD Kromhout
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Apr 27, 1996·Lancet·I SkoogA Svanborg
Jun 25, 1999·Cell·J A Cooper, B W Howell
Jul 15, 1999·JAMA : the Journal of the American Medical Association·M N HaanL Kuller
Nov 24, 1999·Nature Cell Biology·T E WillnowJ Herz
Nov 26, 1999·Neuron·G D'ArcangeloT Curran
Aug 11, 2000·Microscopy Research and Technique·N Helbecque, P Amouyel

❮ Previous
Next ❯

Citations

Jun 9, 2004·Journal of Affective Disorders·Vincent CamusGérard Waeber
Oct 19, 2011·Molecular Psychiatry·M I KambohO L Lopez
Mar 11, 2004·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jorge CervillaSimon Lovestone
Oct 12, 2018·International Journal of Molecular Sciences·Paula Dlugosz, Johannes Nimpf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.